A Novel Heterologous Prime-boost Strategy Using RUTI Vaccine to Improve the Bacillus Calmette-Guérin Response in Non–muscle-invasive Bladder Cancer Patients: Phase 1 RUTIVAC-1 Trial
Buisan, O., Servian, P., Pedreño-Lopez, S., Pagès, J., Urrea, V., Martínez, R., Garcia, E., Cardona, P.-J., Vilaplana, C., Amat, M., … Read More
